Suzan F - Search Results

1

Fatal reactivation of cytomegalovirus infection after use of rituximab for a post-transplantation lymphoproliferative disorder.

Suzan F, Ammor M, Ribrag V. Suzan F, et al. N Engl J Med. 2001 Sep 27;345(13):1000. doi: 10.1056/NEJM200109273451315. N Engl J Med. 2001. PMID: 11575282 No abstract available.

2

Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma.

Soussain C, Suzan F, Hoang-Xuan K, Cassoux N, Levy V, Azar N, Belanger C, Achour E, Ribrag V, Gerber S, Delattre JY, Leblond V. Soussain C, et al. Among authors: suzan f. J Clin Oncol. 2001 Feb 1;19(3):742-9. doi: 10.1200/JCO.2001.19.3.742. J Clin Oncol. 2001. PMID: 11157026 Clinical Trial.

3

Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study.

Lefrère F, Delmer A, Suzan F, Levy V, Belanger C, Djabarri M, Arnulf B, Damaj G, Maillard N, Ribrag V, Janvier M, Sebban C, Casasnovas RO, Bouabdallah R, Dreyfus F, Verkarre V, Delabesse E, Valensi F, McIntyre E, Brousse N, Varet B, Hermine O. Lefrère F, et al. Among authors: suzan f. Leukemia. 2002 Apr;16(4):587-93. doi: 10.1038/sj.leu.2402406. Leukemia. 2002. PMID: 11960337

4

Outcome of elderly patients with aggressive Non-Hodgkin's lymphoma refractory to or relapsing after first-line CHOP or CHOP-like chemotherapy: a low probability of cure.

Jabbour E, Chalhoub B, Suzan F, Aloulou S, Cainap C, Toumi N, Fermé C, Carde P, Ribrag V. Jabbour E, et al. Among authors: suzan f. Leuk Lymphoma. 2004 Jul;45(7):1391-4. doi: 10.1080/10428190310001653736. Leuk Lymphoma. 2004. PMID: 15359638 Review.

5

Phase II trial of CPT-11 in myelodysplastic syndromes with excess of marrow blasts.

Ribrag V, Suzan F, Ravoet C, Feremans W, Guerci A, Dreyfus F, Damaj G, Vantelon JM, Bourhis JH, Fenaux P. Ribrag V, et al. Among authors: suzan f. Leukemia. 2003 Feb;17(2):319-22. doi: 10.1038/sj.leu.2402726. Leukemia. 2003. PMID: 12592329 Clinical Trial.

6

Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer.

Le Deley MC, Suzan F, Cutuli B, Delaloge S, Shamsaldin A, Linassier C, Clisant S, de Vathaire F, Fenaux P, Hill C. Le Deley MC, et al. Among authors: suzan f. J Clin Oncol. 2007 Jan 20;25(3):292-300. doi: 10.1200/JCO.2006.05.9048. Epub 2006 Dec 11. J Clin Oncol. 2007. PMID: 17159192

7

[No title available]

[No authors listed] [No authors listed] PMID: 36164138

8

Despiégel N, Touboul C, Flinois A, Saba G, Suzan F, Gonzalez-McQuire S, Bonnetain F. Despiégel N, et al. Among authors: suzan f. Clin Lymphoma Myeloma Leuk. 2019 Jan;19(1):e13-e28. doi: 10.1016/j.clml.2018.08.019. Epub 2018 Sep 5. Clin Lymphoma Myeloma Leuk. 2019. PMID: 30292736 Free article.

9

A question of class: Treatment options for patients with relapsed and/or refractory multiple myeloma.

Cook G, Zweegman S, Mateos MV, Suzan F, Moreau P. Cook G, et al. Among authors: suzan f. Crit Rev Oncol Hematol. 2018 Jan;121:74-89. doi: 10.1016/j.critrevonc.2017.11.016. Epub 2017 Dec 5. Crit Rev Oncol Hematol. 2018. PMID: 29279102 Free article. Review.

10

Profile of Women Initiated on Denosumab and Pattern of Use in a Restricted Postmenopausal Osteoporosis Indication: A French Database Analysis Over the Period 2013-2014.

Emery C, Gourmelen J, Fagnani F, Suzan F, Desamericq G, Fardellone P. Emery C, et al. Among authors: suzan f. Adv Ther. 2019 Apr;36(4):969-975. doi: 10.1007/s12325-019-00919-4. Epub 2019 Mar 5. Adv Ther. 2019. PMID: 30838517

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page